(196 days)
Not Found
No
The summary describes a device that measures and monitors airway pressure and provides alarms based on set limits. There is no mention of AI, ML, or any related technologies in the intended use, device description, or performance studies. The software is described as "embedded software" developed according to FDA guidelines for moderate level of concern devices, which is typical for standard medical device software and does not imply AI/ML.
No
Explanation: The device is an airway pressure monitor, which measures and monitors airway pressure. It is not listed as directly treating a condition or restoring a bodily function.
No
The device is described as an "Airway Pressure Monitor" that measures and monitors airway pressure, providing alarms when pressure falls outside user-set limits. Its purpose is to continuously monitor and display pressure during CPAP therapy. This falls under monitoring, not diagnosing a condition.
No
The device description explicitly states it is a "compact mains operated monitoring device" and mentions testing of "electrical safety and electromagnetic compatibility," "accessory tubing," and "patient contact materials," all of which indicate the presence of hardware components beyond just software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The NAPA LP-15 Airway Pressure Monitor measures and monitors airway pressure directly in a neonatal patient's airway. It does not analyze samples taken from the body.
- Intended Use: The intended use clearly states it's for measuring and monitoring airway pressure during positive pressure therapy. This is a direct physiological measurement, not an in vitro test.
The device is a physiological monitoring device, not an IVD.
N/A
Intended Use / Indications for Use
The NAPA LP-15 Airway Pressure Monitor is intended to measure and monitor airway pressure for neonatal patients being treated with positive pressure therapy, including neonatal Continuous Positive Airway Pressure (CPAP) devices (e.g. Bubble CPAP). The device provides audible and visual alarms when the airway pressure falls outside of the user selected high and low alarm limits. The device is intended to be pole mounted for stationary use in hospitals only. For professional use only.
Product codes
CAP
Device Description
The NAPA LP-15 Airway Pressure Monitor is a compact mains operated monitoring device that continuously monitors and displays the neonatal patient's average airway treatment pressure during neonatal CPAP therapy (e.g. Bubble CPAP) and provides high and low alarms for pressures that exceed set limits.
NAPA LP-15 Airway Pressure Monitor features:
- . Device measures, monitors, and continuously displays a two second mean airway pressure from 0.0-15.0 cmH₂O with resolution of 0.1 cmH₂O.
- . Manual zero pressure sensor function (zero key).
- User interface provides adjustable audio and visual high and low airway . pressure alarms when the mean airway pressure falls outside of the userselected high and low alarm limits.
- The high alarm settings are from 4.0 to 15 cmH20.
- . Low alarm settings are from 0.1 to 8.0 cmH2O.
- . Alarm Suspend button allows alarm to be silenced for two minutes.
- . Mains operated: The device is supplied with a medically rated power adapter.
- . Single patient use airway measurement tubing with an integral moisture barrier.
- I The NAPA LP-15 Airway Pressure Monitor may be pole mounted with the available pole mount bracket and clamp.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
airway
Indicated Patient Age Range
neonatal patients
Intended User / Care Setting
hospitals only. For professional use only.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Tests Submitted:
The NAPA LP-15 Airway Pressure Monitor including its DC power adapter was laboratory tested to current applicable standards for medical device electrical safety and electromagnetic compatibility as well as collateral standards for alarms. The following standards were utilized in compliance testing:
- Electrical safety testing per IEC 60601-1
- Electromagnetic compatibility testing per IEC 60601-1-2
- Alarms testing per IEC 60601-1-8
- Environmental and mechanical testing per the test levels specified in home healthcare: IEC 60601-1-11; (note informative only: device is not specified for home use)
The monitor met the acceptance criteria for compliance to the standards.
The monitor with accessory tubing was tested for static and pressure measurement accuracy and functional performance with a calibrated reference source.
The monitor met acceptance criteria for pressure accuracy and function.
Risk management, risk and hazard analysis of the monitor/system was performed to the following standard:
- Application of risk management to medical devices per ISO 14971
The monitor met the acceptance criteria for residual risks.
The NAPA LP-15 Airway Pressure Monitor embedded software was developed in accordance with FDA guidelines for MODERATE level of concern devices. The software lifecycle process was evaluated to meet:
- Medical device software lifecycle process per IEC 62304 with software safety class B (equivalent to MODERATE level of concern).
The device software was verified to requirements and validated to meet the specified intended use(s).
The patient contact materials, a cleared tubing set accessory with contact to the patient airway was evaluated for biocompatibility by reference to the manufacturers technical file.
An accelerated aging test was performed for a simulated aging of 3 years.
The monitor met the acceptance criteria for the accelerated aging test.
In summary, the NAPA LP-15 Airway Pressure Monitor met test criteria for standards conformance to the applicable standards, pressure measurement ad accuracy. Residual risks met criteria for acceptability for the intended use.
Clinical Tests Submitted:
No clinical tests were submitted.
Conclusions from Tests:
The NAPA LP-15 Airway Pressure Monitor is equivalent to the predicate device as supported by compliance, and laboratory testing, and risk management and system level software evaluations as described above in the non-clinical testing, and submitted in Sections 16, 17, and 18 of the device 510(k) submission.
The results of all tests demonstrate that the reusable NAPA LP-15 Airway Pressure Monitor is substantially equivalent to the referenced predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Measurement accuracy: +/- 0.5 cm H2O
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 868.2600 Airway pressure monitor.
(a)
Identification. An airway pressure monitor is a device used to measure the pressure in a patient's upper airway. The device may include a pressure gauge and an alarm.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
February 9, 2018
DRW Medical, LLC % Stephen Gorski President Imagenix, Inc. S65 W35739 Piper Road Eagle, Wisconsin 53119
Re: K172284
Trade/Device Name: NAPA LP-15 Airway Pressure Monitor Regulation Number: 21 CFR 868.2600 Regulation Name: Airway Pressure Monitor Regulatory Class: Class II Product Code: CAP Dated: January 8, 2018 Received: January 10, 2018
Dear Stephen Gorski:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
1
801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Michael J. Ryan -S
for Tina Kiang, Ph.D. Acting Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control, and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number
Device Name
NAPA LP-15 Airway Pressure Monitor
Indications for Use (Describe)
The NAPA LP-15 Airway Pressure Monitor is intended to measure and monitor airway pressure for neonatal patients being treated with positive pressure therapy, including neonatal Continuous Positive Airway Pressure (CPAP) devices (e.g. Bubble CPAP). The device provides audible and visual alarms when the airway pressure falls outside of the user selected high and low alarm limits. The device is intended to be pole mounted for stationary use in hospitals only. For professional use only.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
__ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary in accordance with 21 CFR 807.92
| (a) | (1) | Submitted by: | DRW Medical, LLC
811 Lincoln Drive
Brookhaven PA 19015
USA
Tel.: 800-230-6002
Fax: 610-872-6671
Dan(at)wbmedical.com | |
|-----|-----|-----------------------------|----------------------------------------------------------------------------------------------------------------------------------------|---------------------------------|
| | | Contact Person: | Mr. Dan Tatum | |
| | | Position/Title: | Managing Director | |
| | | Date of Preparation: | February 9, 2018 | |
| | (2) | Trade Name: | NAPA LP-15 Airway Pressure Monitor | |
| | | Common/Classification Name: | Monitor, Airway Pressure (Includes Gauge and/Or Alarm); | |
| | | Regulation: | 21 CFR §868.2600 | |
| | | Product Code(s): | CAP | |
| | | Class: | Class II | |
| | (3) | Predicate Device(s): | Substantial Equivalence to: | |
| | | K Number | Model | Manufacturer |
| | | K992101 | Criterion 40 Airway Pressure Monitor | Caradyne Ltd. (now Respironics) |
| | | Reason for Submission: | New Device | |
(4) Description of Device:
The NAPA LP-15 Airway Pressure Monitor is a compact mains operated monitoring device that continuously monitors and displays the neonatal patient's average airway treatment pressure during neonatal CPAP therapy (e.g. Bubble CPAP) and provides high and low alarms for pressures that exceed set limits.
NAPA LP-15 Airway Pressure Monitor features:
- . Device measures, monitors, and continuously displays a two second mean airway pressure from 0.0-15.0 cmH₂O with resolution of 0.1 cmH₂O.
- . Manual zero pressure sensor function (zero key).
4
- User interface provides adjustable audio and visual high and low airway . pressure alarms when the mean airway pressure falls outside of the userselected high and low alarm limits.
- The high alarm settings are from 4.0 to 15 cmH20.
- . Low alarm settings are from 0.1 to 8.0 cmH2O.
- . Alarm Suspend button allows alarm to be silenced for two minutes.
- . Mains operated: The device is supplied with a medically rated power adapter.
- . Single patient use airway measurement tubing with an integral moisture barrier.
- I The NAPA LP-15 Airway Pressure Monitor may be pole mounted with the available pole mount bracket and clamp.
(5) Intended use:
The NAPA LP-15 Airway Pressure Monitor provides pressure measurement resolution and alarm adjustment ranges which are tailored to the treatment ranges of neonatal BCPAP treatment (0 - 15 cmH2O). These allow a clinician to set the alarm thresholds to sense the small drops in pressure that may occur in neonatal CPAP treatment (e.a. Bubble CPAP). The device is specified for professional use in a healthcare facility.
Indications for Use:
The NAPA LP-15 Airway Pressure Monitor is intended to measure and monitor mean airway pressure for neonatal patients being treated with positive pressure therapy, including neonatal Continuous Positive Airway Pressure (CPAP) devices (e.g. Bubble CPAP). The device provides audible and visual alarms when the airway pressure falls outside of the user selected high and low alarm limits. The device is intended to be pole mounted for stationary use in hospitals only. For professional use only.
Prescription device (Rx).
Discussion of Differences in Indications to the Predicate Devices:
The submitted device and referenced predicate devices have the following differences in their indication statements regarding pressure monitoring:
- . The specified patient population for the NAPA LP-15 Airway Pressure Monitor is neonatal patients only. The Criterion 40 Airway Pressure Monitor has no specified patient population (i.e. adult through neonatal population possible). The NAPA LP-15 Airway Pressure Monitor claims are within the claimed population of the predicate device.
- . The predicate monitor displays peak pressure and real-time airway pressures, the NAPA LP-15 Airway Pressure Monitor only provides an average (mean) CPAP treatment pressure.
- . The predicate monitor may be used with positive pressure devices which do not include pressure measurement capabilities, e.q. resuscitation bags or basic ventilators, or as an independent backup pressure monitor for devices with pressure measurement capability. NAPA LP-15 Airway Pressure Monitor only
5
claims monitoring of positive pressure therapy, including neonatal Continuous Positive Airway Pressure (CPAP) devices (e.g. Bubble CPAP).
The differences in the wording of subject and predicate device indications for use are within the scope of the predicate device for intended use of the subject device as a neonatal airway pressure monitor when used as labeled.
(6) Technological Characteristics:
Both the NAPA LP-15 Airway Pressure Monitor and the Criterion 40 are microprocessor controlled devices for measuring patient airway pressure using the same technological principles. Refer to the following comparison table:
Comparison of Technological Features to Predicate Devices:
| Product/Feature | DRW Medical NAPA LP-15
Airway Pressure Monitor | Caradyne Criterion 40
Airway Pressure Monitor | Remark |
|-----------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------|
| Manufacturer | DRW Medical LLC | Caradyne Ltd. (now
Respironics) | |
| Model Number(s) | NAPA LP-15 | Criterion 40 | |
| 510(k) Number | K172284 | K992101 | |
| Intended
Use/Application | Measure mean airway
pressure for neonatal patients
being treated with positive
pressure therapy, including
neonatal CPAP (e.g. Bubble
CPAP). | Measure airway pressure for
any patient utilizing positive
pressure devices where
monitoring is desired | Different, and
within the scope of
predicate device. |
| Patient Population | Neonatal patients | (none specified: not limited
to specific patient type) | Different, and
within the scope of
predicate device. |
| Environment of Care | Hospitals | Hospital, home, and sub-
acute institutions; stationary
and intra-institution transport | Different, and
within the scope of
predicate device. |
| Patient Interface | Disposable single patient use
pressure measurement tubing
from patient's airway to
monitor | Disposable single patient
use pressure measurement
tubing from patient's airway
to monitor | Identical |
| Alarms | ✓ YES | ✓ YES | Identical |
| Measurement
principle | Solid state pressure sensor | Solid state pressure sensor | Identical |
| Control System | Internal microprocessor | Internal microprocessor | Identical |
| Displayed pressure
measurement(s) | Average (Mean) Pressure | Peak Pressure, Real Time
Pressure, Average Pressure | Different, and
within the scope of
predicate device. |
| Specified pressure
measurement range | 0 - 15.0 cm H2O | 0 - 99.5 cm H2O | Different, and
within the scope of
predicate device. |
6
Page 4 of 5
| Product/Feature | DRW Medical NAPA LP-15
Airway Pressure Monitor | Caradyne Criterion 40
Airway Pressure Monitor | Remark |
|----------------------------------|------------------------------------------------------------------------------------|-----------------------------------------------------------------|------------------------------------------------------------|
| Measurement
accuracy | $\pm$ 0.5 cm H2O | $\pm$ 1 + 3% of reading,
rounded up to nearest 0.5
cm H2O | |
| Displayed pressure
resolution | 0.1 cm H2O | 0.5 cm H2O | Different, and
within the scope of
predicate device. |
| Low alarm range | 0.1 - 8.0 cm H2O;
0.1 cm H2O resolution | 1 - 20 cm H2O;
1 cm H2O resolution | Different, and
within the scope of
predicate device. |
| High alarm range | 4.0 - 15.0 cm H₂O;
0.1 cm H2O resolution;
1 cm H₂O resolution > 10 cm
H2O | 5 - 99 cm H2O;
1 cm H2O resolution | Different, and
within the scope of
predicate device. |
| Overall dimensions: | H: 127 mm (5.0 in.)
W: 64 mm (2.5 in.)
D: 32 mm (1.24 in.) | W: 198 mm
H: 94 mm
D: 188 mm | |
| Weight | 180 grams (0.4 lb.) | 680g | |
| Pole mount | ✓ YES, with offered bracket
and clamp | ✓ YES, option | |
| AC Mains Power
Adapter Type | Medically rated external plug
in power supply: AC Mains
input, DC output | External plug in power
supply: AC Mains input, DC
output | |
As summarized above, the NAPA LP-15 Airway Pressure Monitor utilizes equivalent technological characteristics and specifications as the listed predicate devices.
(b) (1) Non-Clinical Tests Submitted:
The NAPA LP-15 Airway Pressure Monitor including its DC power adapter was laboratory tested to current applicable standards for medical device electrical safety and electromagnetic compatibility as well as collateral standards for alarms. The following standards were utilized in compliance testing:
- Electrical safety testing per IEC 60601-1 ●
- Electromagnetic compatibility testing per IEC 60601-1-2 .
- Alarms testing per IEC 60601-1-8 ●
- . Environmental and mechanical testing per the test levels specified in home healthcare: IEC 60601-1-11; (note informative only: device is not specified for home use)
The monitor met the acceptance criteria for compliance to the standards.
The monitor with accessory tubing was tested for static and pressure measurement accuracy and functional performance with a calibrated reference source.
The monitor met acceptance criteria for pressure accuracy and function.
7
Risk management, risk and hazard analysis of the monitor/system was performed to the following standard:
- Application of risk management to medical devices per ISO 14971
The monitor met the acceptance criteria for residual risks.
The NAPA LP-15 Airway Pressure Monitor embedded software was developed in accordance with FDA guidelines for MODERATE level of concern devices. The software lifecycle process was evaluated to meet:
- Medical device software lifecycle process per IEC 62304 with software safety ● class B (equivalent to MODERATE level of concern).
The device software was verified to requirements and validated to meet the specified intended use(s).
The patient contact materials, a cleared tubing set accessory with contact to the patient airway was evaluated for biocompatibility by reference to the manufacturers technical file.
An accelerated aging test was performed for a simulated aging of 3 years.
The monitor met the acceptance criteria for the accelerated aging test.
In summary, the NAPA LP-15 Airway Pressure Monitor met test criteria for standards conformance to the applicable standards, pressure measurement ad accuracy. Residual risks met criteria for acceptability for the intended use.
Clinical Tests Submitted: (2)
No clinical tests were submitted.
(3) Conclusions from Tests:
As described in (b)(1) and (b)(2) above, the NAPA LP-15 Airway Pressure Monitor is equivalent to the predicate device as supported by compliance, and laboratory testing, and risk management and system level software evaluations as described above in the non-clinical testing, and submitted in Sections 16, 17, and 18 of the device 510(k) submission.
The results of all tests demonstrate that the reusable NAPA LP-15 Airway Pressure Monitor is substantially equivalent to the referenced predicate device.